| Infection and rapid transmission of SARS-CoV-2 in ferrets YI Kim, SG Kim, SM Kim, EH Kim, SJ Park, KM Yu, JH Chang, EJ Kim, ... Cell host & microbe 27 (5), 704-709. e2, 2020 | 1077 | 2020 |
| Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 JS Lee, S Park, HW Jeong, JY Ahn, SJ Choi, H Lee, B Choi, SK Nam, ... Science immunology 5 (49), eabd1554, 2020 | 767 | 2020 |
| Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea SY Bin, JY Heo, MS Song, J Lee, EH Kim, SJ Park, H Kwon, S Kim, Y Kim, ... Clinical infectious diseases 62 (6), 755-760, 2016 | 254 | 2016 |
| Viable SARS-CoV-2 in various specimens from COVID-19 patients HW Jeong, SM Kim, HS Kim, YI Kim, JH Kim, JY Cho, S Kim, H Kang, ... Clinical Microbiology and Infection 26 (11), 1520-1524, 2020 | 228 | 2020 |
| SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells JH Jung, MS Rha, M Sa, HK Choi, JH Jeon, H Seok, DW Park, SH Park, ... Nature communications 12 (1), 4043, 2021 | 217 | 2021 |
| PD-1-expressing SARS-CoV-2-specific CD8+ T cells are not exhausted, but functional in patients with COVID-19 MS Rha, HW Jeong, JH Ko, SJ Choi, IH Seo, JS Lee, M Sa, AR Kim, ... Immunity 54 (1), 44-52. e3, 2021 | 211 | 2021 |
| Severe fever with thrombocytopenia syndrome in South Korea, 2013-2015 SJ Choi, SW Park, IG Bae, SH Kim, SY Ryu, HA Kim, HC Jang, J Hur, ... PLoS neglected tropical diseases 10 (12), e0005264, 2016 | 177 | 2016 |
| In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii JY Song, SY Kee, IS Hwang, YB Seo, HW Jeong, WJ Kim, HJ Cheong Journal of Antimicrobial Chemotherapy 60 (2), 317-322, 2007 | 175 | 2007 |
| Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets SJ Park, KM Yu, YI Kim, SM Kim, EH Kim, SG Kim, EJ Kim, MAB Casel, ... MBio 11 (3), 10.1128/mbio. 01114-20, 2020 | 159 | 2020 |
| Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea WS Choi, CI Kang, Y Kim, JP Choi, JS Joh, HS Shin, G Kim, KR Peck, ... Infection & chemotherapy 48 (2), 118-126, 2016 | 151 | 2016 |
| An outbreak of post-acupuncture cutaneous infection due to Mycobacterium abscessus JY Song, JW Sohn, HW Jeong, HJ Cheong, WJ Kim, MJ Kim BMC infectious diseases 6, 1-7, 2006 | 111 | 2006 |
| Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection YJ Kim, SI Kim, YR Kim, KW Hong, SH Wie, YJ Park, H Jeong, MW Kang Epidemiology & Infection 140 (1), 137-145, 2012 | 102 | 2012 |
| Effect of a hospital campaign for influenza vaccination of healthcare workers JY Song, CW Park, HW Jeong, HJ Cheong, WJ Kim, SR Kim Infection Control & Hospital Epidemiology 27 (6), 612-617, 2006 | 93 | 2006 |
| SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern JY Noh, HW Jeong, EC Shin Signal Transduction and Targeted Therapy 6 (1), 203, 2021 | 87 | 2021 |
| T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant SJ Choi, DU Kim, JY Noh, S Kim, SH Park, HW Jeong, EC Shin Cellular & molecular immunology 19 (3), 447-448, 2022 | 83 | 2022 |
| Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea SM Yun, SJ Park, YI Kim, SW Park, MA Yu, HI Kwon, EH Kim, KM Yu, ... JCI insight 5 (2), 2020 | 71 | 2020 |
| Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission YI Kim, SM Kim, SJ Park, EH Kim, KM Yu, JH Chang, EJ Kim, MAB Casel, ... Emerging microbes & infections 10 (1), 152-160, 2021 | 69 | 2021 |
| Molecular genomic characterization of tick-and human-derived severe fever with thrombocytopenia syndrome virus isolates from South Korea SM Yun, SJ Park, SW Park, WY Choi, HW Jeong, YK Choi, WJ Lee PLoS neglected tropical diseases 11 (9), e0005893, 2017 | 66 | 2017 |
| T cell-oriented strategies for controlling the COVID-19 pandemic JY Noh, HW Jeong, JH Kim, EC Shin Nature Reviews Immunology 21 (11), 687-688, 2021 | 63 | 2021 |
| Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance KW Hong, HJ Cheong, WS Choi, J Lee, SH Wie, JH Baek, HY Kim, ... Journal of Infection and Chemotherapy 20 (1), 9-14, 2014 | 61 | 2014 |
Woo Joo KimProfessor of Medicine, Korea University College of Medicine在 korea.ac.kr 的电子邮件经过验证
Woo Joo KimProfessor of Medicine, Korea University College of Medicine在 korea.ac.kr 的电子邮件经过验证